Sanara MedTech (SMTI)
(Real Time Quote from BATS)
$33.46 USD
+0.36 (1.09%)
Updated Sep 24, 2025 10:02 AM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SMTI 33.46 +0.36(1.09%)
Will SMTI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SMTI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SMTI
Sanara MedTech Inc. (SMTI) Reports Q2 Loss, Tops Revenue Estimates
Cresco Labs Inc. (CRLBF) Reports Q2 Loss, Lags Revenue Estimates
SMTI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sanara MedTech Inc. (SMTI) Reports Q1 Loss, Tops Revenue Estimates
Insulet (PODD) Q1 Earnings and Revenues Surpass Estimates
Sanara MedTech (SMTI) Stock Jumps 8.1%: Will It Continue to Soar?
Other News for SMTI
20 Day Moving Average Resistance appears for SMTI after 2.14% move
Is SMTI about to break its pattern? Bollinger Band Squeeze shows up after gaining 2.84%
Fell Below 20 Day Moving Average appears for SMTI after 5.05% move
Technical picture remains unchanged for SMTI after it rises 1.32% on September 18
SMTI falls 2.54% on September 18, leaving the technical picture intact